Jeremy C. Durack

United States Department of Veterans Affairs

Also affiliated with Memorial Sloan Kettering Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058

Top 20%

1.0DataRank

Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

Papers

Driven by 9 papers — median percentile 80. Top paper: “Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study”.

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0855

N/A

2.2DataRank · unranked

68 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058

Top 20%

1.0DataRank

Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study

The Lancet Oncology(2022)10.1016/s1470-2045(22)00251-0

N/A

0.661DataRank · unranked

81 citations

Clare M. Tempany, Ford Holland, Daniel D. Sjoberg, Adam S. Kibel, Quoc‐Dien Trinh +16 more

A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.323

N/A

0DataRank · unranked

5 citations

Kyrollis Attalla, Sujata Patil, Samuel Murray, Ying‐Bei Chen, Ritesh R. Kotecha +5 more

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

The Journal of Urology(2021)10.1097/ju.0000000000001698

N/A

0DataRank · unranked

381 citations

Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frédéric Pouliot, Stephan Probst +12 more

Evaluation of an Integrated Spectroscopy and Classification Platform for Point-of-Care Core Needle Biopsy Assessment: Performance Characteristics from Ex Vivo Renal Mass Biopsies

Journal of Vascular and Interventional Radiology(2022)10.1016/j.jvir.2022.07.027

N/A

0DataRank · unranked

1 citations

Dmitry V. Dylov, Siavash Yazdanfar, Dharam Patel, Tarik Silk, Mikhail Silk +9 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578.v1

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.07.007

N/A

0DataRank · unranked

5 citations

Hebert Alberto Vargas, Daniel J. Holzwanger, Heiko Schöder, Emily Waters, Elena N. Petre +13 more

Jeremy C. Durack

Indexed papers

Top data-sharing exemplar

Papers